EPH161 Dose Escalation Patterns in Patients with Overweight or Obesity Initiating Semaglutide 2.4mg: A 6-Month Follow-up in a Real-World Setting in the United States
Abstract
Authors
L. Lv W. Michalak B Ó Hartaigh Z. Zhao A. Fabricatore